Core Viewpoint - The article discusses the transformative potential of biomanufacturing, particularly focusing on the advancements in recombinant collagen production by Juzhi Biotechnology, which has positioned itself as a leader in this emerging industry in China [2][14]. Group 1: Biomanufacturing Overview - Biomanufacturing is defined as a process that utilizes biological catalysts such as microorganisms and enzymes to efficiently synthesize and convert materials, representing a shift from traditional manufacturing methods [2]. - By 2026, biomanufacturing is expected to be one of the six future industries prioritized in China's 14th Five-Year Plan, with a total scale reaching 1.1 trillion yuan [2]. Group 2: Juzhi Biotechnology's Innovations - Juzhi Biotechnology has pioneered the development of recombinant collagen, achieving a significant milestone in 2000 when it became the first in China to produce it using synthetic biology techniques [5][7]. - The company has launched flagship brands such as Keli Jin and Kefu Mei, focusing on scientific skincare solutions for issues like wrinkles and skin repair [7]. - Juzhi has received over 20 national and provincial awards, including the National Technology Invention Award, and has been recognized as a global leader in recombinant collagen for two consecutive years by Euromonitor International [7][9]. Group 3: Market Dynamics and Challenges - The recombinant collagen market is experiencing explosive growth, with increasing competition and a need for standardized quality control, as highlighted by the introduction of industry standards by the National Medical Products Administration [10][12]. - Juzhi Biotechnology is actively involved in the formulation of these standards, addressing challenges such as production costs, application technologies, and the need for a comprehensive evaluation system [12]. Group 4: Future Prospects - The company is exploring new applications for recombinant collagen, including potential uses in bone, vascular, and nerve repair, which could lead to the development of advanced biomaterials and artificial organs [15]. - The integration of AI technologies is expected to enhance research efficiency and production quality, positioning Juzhi Biotechnology to lead in innovation within the biomanufacturing sector [12][15]. Group 5: Commitment to Transparency and Consumer Trust - Juzhi Biotechnology emphasizes transparency in its production processes, planning to showcase its entire R&D and manufacturing workflow to consumers, thereby building trust and confidence in its products [13].
重组胶原蛋白，为什么是“未来产业”？